The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of type of antibiotics (Abx) on outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial carcinoma (mUC) in a real-world setting.
 
Charbel Hobeika
No Relationships to Disclose
 
Scott Dawsey
Honoraria - MJH Life Sciences
 
Ubenthira Patgunarajah
No Relationships to Disclose
 
David Lynn
No Relationships to Disclose
 
Nikhil Pramod
No Relationships to Disclose
 
Wei Wei
No Relationships to Disclose
 
Monica Nair
No Relationships to Disclose
 
Kimberly Maroli
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Travel, Accommodations, Expenses - AVEO
 
Allison Martin
No Relationships to Disclose
 
Moshe Chaim Ornstein
Consulting or Advisory Role - AVEO; Bristol Myers Squibb Foundation; Eisai; Exelixis; Merck; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Aravive (Inst); Astellas Medivation (Inst); AstraZeneca/MedImmune (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Surface Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Exelixis; Merck; Pfizer
 
Christopher Eing Wee
Consulting or Advisory Role - Bayer HealthCare Pharmacuticals; Janssen
 
Timothy D. Gilligan
No Relationships to Disclose
 
Amanda Nizam
Honoraria - Aptitude Health; Cleveland Clinic
Consulting or Advisory Role - AVEO
Travel, Accommodations, Expenses - ASCO
 
Amanda Bonham
No Relationships to Disclose
 
Omar Y. Mian
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics
Research Funding - Gilead Sciences (Inst); PathomIQ (Inst); Varian Medical Systems (Inst)
Travel, Accommodations, Expenses - Varian Medical Systems
(OPTIONAL) Uncompensated Relationships - Veracyte
 
Paul G. Pavicic
No Relationships to Disclose
 
C. Marcela Diaz-Montero
No Relationships to Disclose
 
Shilpa Gupta
Stock and Other Ownership Interests - BioNTech SE; Moderna Therapeutics; Nektar
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb/Medarex; EMD Serono; Foundation Medicine; Gilead Sciences; Merck; Pfizer; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Gilead Sciences; Janssen Oncology; Seagen
Research Funding - Bristol Myers Squibb Foundation (Inst); EMD Serono (Inst); Exelixis (Inst); Gilead Sciences (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); QED Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)